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miRNA expression proﬁlingMicro RNAs (miRNA) are non-coding RNAs expressed in the cytoplasm as their mature, 21–22-nucle-
otide short forms. More recently, mature miRNAs have also been detected in the nucleus, raising the
possibility that their spatial distribution may be more complex than anticipated. Here we undertook
comprehensive systematic analyses of miRNA distribution in several subcellular compartments of
human cancer cells. In particular, we focused on the potential presence of miRNAs in the nucleolus,
which contains an abundance of small non-coding RNAs. We employed two miRNA expression array
platforms and small RNA deep sequencing of small RNAs isolated from cells, nuclei, cytoplasm and
the nucleoli. We developed an assay to compare RNAs of isolated nucleoli before and after
denaturation and used Northern hybridization to verify the presence of miRNAs in the subcellular
compartments. Consistently, we found more than 10 miRNAs associated with the nucleolar
preparations. Several miRNAs had greater relative abundance in the nucleolus compared to the
other compartments. The nucleolar presence of miRNAs was independent of Dicer and the main
activity of the nucleolus, RNA polymerase I transcription, but was dependent on CRM1 previously
associated with nucleolar trafﬁcking of small nucleolar RNAs. These results highlight the complexity
of miRNA spatial arrangement and regulation.
 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
MicroRNAs (miRNAs) are evolutionary conserved single-
stranded 22 nt RNA species implicated in a broad range of
physiological and developmental processes [1,2]. MiRNAs are tran-
scribed mainly by RNA polymerase II as long primary transcripts,
processed by Drosha and DGCR8 microprocessor complex, and
transported to the cytoplasm by the nuclear export factor
exportin-5 [3]. The cytoplasmic precursor (pre) miRNA is further
cleaved by Dicer to 22 nt RNA duplex and loaded by Argonauteproteins to generate the RISC silencing complex [3]. MiRNAs
recognize their target mRNAs in their 30UTRs and thus act in the
cytoplasm to repress mRNA translation and to accelerate mRNA
decay [1]. The canonical miRNA processing pathway is extensively
posttranscriptionally modiﬁed by proteins that interfere or
augment the microprocessor or Dicer activity and miRNA stability
[4–6]. Many of these processes intersect with regulation and
synthesis of other short RNAs, most notably short interfering RNAs
(siRNAs) and mirtrons [3]. MiRNAs are expressed in tissue-speciﬁc
manner and depend on developmental stage, but their regulation is
frequently abnormal in human disease [7–11].
Based on their known functions, mature miRNAs have been
mainly considered cytoplasmic. However, miRNA nuclear localiza-
tion signals have been identiﬁed [12], and RNA deep sequencing
and expression analyses have indicated that mature forms co-exist
both in the cytoplasm and the nucleus [13]. Further, a few miRNAs
have been identiﬁed with presumably nuclear functions [14,15].
MiRNAs have been described in the nucleoli of rat myoblasts,
mouse Sertoli cells and human cancer cell lines [16–19], and pres-
ence of precursor miRNA forms have been proposed, but not con-
ﬁrmed, in the nucleoli [17,20,21]. MiRNA-binding and processing
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possibility that miRNAs may display more complex cellular
locations, and possibly, associated functions, than anticipated
[22–24].
The nucleolus has a uniquely rich RNA content composed
mainly of ribosomal (r) RNAs and small nucleolar (sno) RNAs.
RNA polymerase I (Pol I) transcription is the main metabolic activ-
ity of the nucleolus that entails transcription of a long rRNA pre-
cursor, and its processing, maturation and modiﬁcation of the
5.8S, 18S and 28S rRNAs assembled in the small and large 40S
and 60S ribosomes, respectively [25–27]. The nucleolus has an
exquisite concentration of double-stranded RNA-binding proteins,
several of which exhibit nucleocytoplasmic shuttling and are
involved in nuclear export of their main cargo, ribosomes. In addi-
tion, nucleolar proteomics, imaging and spatial analyses have dem-
onstrated highly dynamic features of the nucleolus [28,29]. These
are evident ﬁrstly by the high output of the nucleolus in terms of
ribosome production in response to normal extracellular cues
and growth stimuli [27], and secondly, rapid changes in proteome
and RNA content in response to transcription and viral stresses
[28,29].
The processing and editing of rRNA in the nucleolus involves the
activity of small non-coding RNAs. SnoRNAs are small abundant
RNAs that function in rRNA processing [30,31]. Box C/D and box
H/ACA snoRNAs have short (3–7 nt) consensus motifs that direct
their nucleolar localization and protein interaction [30,32]. They
are typically transcribed in the nucleoplasm, transported to the
nucleoli either directly or through subnucleolar Cajal bodies in a
manner that surprisingly requires the nuclear export protein
exportin-1 (CRM1) [33]. Interestingly, CRM1, besides its nucleo-
plasmic location, localizes also to nucleoli where it recognizes its
cargo [34–39]. SnoRNAs fold to speciﬁc secondary structures and
assemble with a deﬁned set of proteins to fulﬁll their functions
as guide RNAs to assist rRNA maturation [31]. SnoRNAs and miR-
NAs have interesting parallels. Recently, miRNA precursors have
been found to resemble snoRNAs, display H/ACA like structures
and bind to dyskerin, present in the H/ACA ribonucleoprotein com-
plex [20,21,40–43]. Processing of these snoRNA-derived miRNAs
require Dicer, but are independent of Drosha [21,44]. Whether
the miRNA-like snoRNAs are transported to cytoplasm for the
Dicer-mediated processing is not know.
Given the previous ﬁndings on miRNA-like properties of snoR-
NAs and ﬁndings of isolated miRNAs in the nucleolus, we consid-
ered relevant to address the nucleolar small RNAome contents.
However, no large-scale small RNA deep sequencing studies have
been conducted to date to provide a comprehensive outlook. For
this purpose, we analyzed subcellular localization of miRNAs, and
speciﬁcally, their presence in the nucleolus. We analyzed small
RNA content in total, cytoplasmic, nuclear and nucleolar RNA iso-
lates using expression array platforms, deep sequencing and
Northern analysis in two human cancer cell lines. These analyses
revealed that several miRNAs were frequently, and consistently,
detected in small RNA nucleolar fractions. These ﬁndings suggest
that the nucleolus represents a small RNA depot that includes
miRNAs.
2. Materials and methods
2.1. Cell line and reagents
HeLa cervical adenocarcinoma cells (CCL-2, ATCC) and HCT116
cells (wt and DICER/) were maintained in DMEM and 10% FCS.
The HCT116 DICER/ cells were a kind gift of Dr. Velculescu
(Johns Hopkins University, Baltimore, MD). MCF7 breast
adenocarcinoma cells (HTB22, ATCC) were maintained in MEMsupplemented with 10% FCS and non-essential amino acids. All cell
culture reagents were obtained from Invitrogen. The following
drugs were used; Actinomycin D (Sigma–Aldrich), Leptomycin B
(Sigma–Aldrich).
2.2. Fractionation of cells and isolation of RNA
Nuclear, nucleolar and cytoplasmic fractions were prepared
essentially as in our previous study [45]. RNA was extracted from
subcellular compartments using TRIzol Reagent (Invitrogen). From
a starting population of about 1.8  108 cells, 6% of the nuclei were
used for extraction of nuclear RNA (typically yielding 120 lg RNA),
and the rest (94%) was used for extraction of nucleoli and nucleolar
RNA (typically yielding 40–160 lg RNA). Of the cytoplasmic frac-
tion corresponding to 1.8  108 cells, 1.6% was used for extraction
of cytoplasmic RNA (typically yielding 240 lg RNA). This leads to a
RNA output ratio of 1:10:80 per nucleolus/nucleus/cytoplasm.
2.3. NCode™ microRNA proﬁling
Total RNAwas extracted fromwhole cells and nucleoli using the
TRIzol Reagent (Invitrogen) according to the manufacturer’s
instructions. Small RNAs (<200 nt) were further enriched using
mirVana kit (Ambion). The small RNAs were poly-A tailed and
tagged with the sequence tag for either Alexa Fluor 5 ﬂuorophor
or Alexa Fluor 3 ﬂuorophor using the NCode™ miRNA Labeling
System (Invitrogen). The samples were hybridized in triplicate to
NCode™ Multi-Species miRNA Microarray (Invitrogen) overnight
according to the instructions by the manufacturer. The microarrays
were then hybridized with Alexa Fluor 3 and Alexa Fluor 5 cap-
ture reagents and washed. Hybridization was performed on a
MAUI hybridization station (BioMicro Systems Inc). Each array
was subsequently scanned using an Agilent DNA microarray scan-
ner, and images were processed using GenePix Pro software
(Molecular Devices). Data analyses were conducted using R statis-
tical program. Nucleolar and cellular miRNA intensities were nor-
malized according to intensities of 6–7 snoRNAs included in the
arrays. HeLa and MCF7 cellular intensities were normalized by fold
difference of their averaged cellular intensity.
2.4. Heat-treatment of nucleoli and quantitative RT-PCR
Equal amount of freshly puriﬁed HeLa nucleolus suspension
was either heated to 95 C (‘‘heat-denatured nucleolus’’) for
5 min or incubated on ice for 5 min (intact nucleolus). The nucleoli
were then subjected directly to reverse transcription using Super-
Script III Reverse Transcriptase (Invitrogen) and random hexa-
mers according to the manufacturer’s instructions. QPCR was
performed using SYBR Green (Atila Biosystem) and speciﬁc primer
pairs. Ampliﬁcation was conducted for 38 cycles at 94 C for 10 s
and at 60 C for 1 min each using an ABI7900 thermocycler
(Applied Biosystems). DCt represents Ct heat-denaturated nucleoli
– Ct non-denatured nucleoli. The primer sequences used were as
follows: RNU44: 50-CCTGGATGATGATAGCAAATGC-30 and 50-GAG-
CTAATTAAGACCTTCATGTT-30; RNU48: 50-AGTGATGATGACCC-
CAGGTAA-30 and 50-GTGATGGCATCAGCGACACA-30; HBII-239: 50-
GAAGCAGTGGGAGTGGAGAA-30 and 50-TCAGCAGTTTGAGTGT-
CAGCA-30; hY1: 50-GGCTGGTCCGAAGGTAGTGA-30 and 50-GCAG-
TAGTGAGAAGGGGGGA-30; hY3: 50-GGCTGGTCCGAGTGCAGTG-30
and 50-GAAGCAGTGGGAGTGGAGAA-30; U1: 50-ATACTTACCTGG
CAGGGGAGA-30 and 50-CAGGGGGAAAGCGCGAACGCA-30; U2: 50-
ATCGCTTCTCGGCCTTTTTG-30 and 50-TCCTATTCCATCTCCCTGCTC-
30. Primers for miR-206, miR-23a and miR-100 were from Applied
Biosystems (TaqMan miRNA Assays ID 000510, ID 000399 and ID
000437).
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Comparisons of global miRNA expression proﬁles in intact and
heat-treated nucleoli were performed using the TaqMan Array
Human MicroRNA Panel v2.0 (Applied Biosystems), which includes
Cards A and B in a 384-well format. These contain assays for
quantiﬁcation of 664 human miRNAs and 7 control RNAs. The
experimental procedures were according to the manufacturer’s
instructions. In brief, suspension of intact and heat-treated nucleoli
were directly subjected to reverse-transcription using the Multi-
plex RT pool set (Applied Biosystems) and the High-Capacity cDNA
Archive Kit (Applied Biosystems), whereby a stem-loop RT primer
speciﬁcally binds to its corresponding miRNA and initiates its
reverse-transcription. The reaction products were subsequently
ampliﬁed with sequence-speciﬁc primers using the Applied Biosys-
tems 7900 HT Real-Time PCR system. The reactions were incubated
in a 384-well plate at 95 C for 10 min followed by 40 cycles at
95 C for 15 s and at 60 C for 1 min. The data were collected and
processed using the Plate Utility and Automation Controller soft-
ware (Applied Biosystems).
2.6. RNA isolation and generation of cDNA libraries
Total RNA was extracted from whole cells and the isolated cel-
lular compartments using TRIzol Reagent according to manufac-
turer’s instructions as outlined in our previous study [45] and
manuscript submitted. Approximately 400 lg total RNA from each
compartment was used to prepare cDNA libraries. Brieﬂy, small
RNAs (less than 200 nt) were isolated from the total RNA samples
using mirVana Isolation Kit (Ambion) and separated on denaturing
15% polyacrylamide gel (15% PAA, 19:1 acrylamide/bis, 7 M urea)
to purify RNAs in the approximate range of 10–40 nt. The small
RNA size range was conﬁrmed and the RNA was quantiﬁed using
Bioanalyzer and the Agilent Small RNA kit (Agilent). cDNA libraries
were constructed using the Ion Torrent RNA-seq kit v1 for small
RNA libraries according to manufacturer’s instructions, and their
purity and concentration was conﬁrmed using Bioanalyzer with
the Agilent DNA kit. Small RNA library sequencing was performed
using a 314 chip on an Ion Torrent sequencing platform (Life Tech-
nologies, Invitrogen) at the Sidney Kimmel Comprehensive Cancer
Center Next Generation Sequencing Core. Raw data is deposited to
GEO: GSE50057.
2.7. Northern hybridization
Northern blotting was carried out according to Ref. [12]
with some modiﬁcations. Brieﬂy, 20 lg RNA were resolved on
denaturing polyacrylamide gels in 1X TBE, transferred onto a
positively charged nylon membrane (Roche Diagnostics) using
semi-dry electroblotting (Bio-Rad), and immobilized by UV irra-
diation (Stratagene Crosslinker 120 mJ/cm2). The membrane
was pre-hybridized with hybridization buffer at 37 C for 1 h,
and then hybridized overnight at 37 C with speciﬁc oligode-
oxynucleotides. The probes were labeled with Digoxigenin
using the DIG oligonucleotide 30END labeling kit (Roche) and
detected using the DIG Nucleic Acid Detection Kit (Roche).
The following probes were used: RNU44: 50-AGTTAGAGCTAAT-
TAAGACCT-30; tRNA-Ile, 50-UGGUGGCCCGUACGGGGAUCGA-30;
U11: 50-TCTTGATGTCGATTCCGCACGCAGAGCAATCGAGTTGCCC-
30; hY1: 50-AAGGGGGGAAAGAGTAGAACA-30. The probes were
synthesized at the Johns Hopkins Genetic Resources Core Facil-
ity. The miRCURY locked nucleic acid (LNA) Digoxigenin-
labeled probes for detection of miR-19b, miR-21, miR-23a,
miR-24, miR-30c, miR-31, miR-99a and miR-191 were pur-
chased from Exiqon.3. Results
3.1. MiRNA expression arrays of nucleolar RNA
We conducted miRNA expression proﬁling of HeLa cervical and
MCF7 breast adenocarcinoma cells. For this purpose, we isolated
nucleoli and puriﬁed small RNAs from the nucleolar preparation
and from total cellular RNA. The nucleoli were visually veriﬁed
for 99% purity under phase contrast and by staining the nucleoli
for nucleolar marker protein nucleophosmin (not shown). Analysis
of small RNAs by 16% denaturing PAGE showed that the RNAs were
distinct (Fig. 1A). The RNAs were dual-color labeled and hybridized
to NCode Multispecies miRNA array v.2 using three technical
repeats. Signals of over 60% miRNAs present in the array were
detected in both cell lines. The nucleolar signal intensities were
normalized according to several snoRNAs present in the array
(e.g. U46, U47, U49, U50, HBII-13, HBII-239 and HBII-436), and data
for high-ranking miRNAs are shown in Supplementary Table S1. As
shown in Fig. 1B and C, high-intensity signals were detected in
both cell lines in the total cellular and nucleolar RNA preparations.
Scatter plot graphs showed that cellular miRNA content correlated
with nucleolar signal intensity (Pearson correlation coefﬁciency,
r = 0.843) in HeLa cells, whereas modest correlation was observed
in MCF7 cells (r = 0.567). In HeLa and MCF7 nucleolar RNA isolates,
78% of top-ranking 46 miRNAs were identical, and their intensities
were highly associated (Fig. 1D and E). However, the intensities of
cellular miRNAs in the cell lines were not (Fig. 1F). Data derived
from HeLa cells was suggestive that highly expressed miRNAs were
detected also in the nucleolar RNA preparation.
However, cellular RNAs present in the nucleolar preparation
may confound this interpretation. We hence decided to test an
approach that beneﬁts from the highly compact structure of the
nucleolus. We reasoned that if non-nucleolar RNAs are present in
the nucleolar preparation there would be a substantial difference
in the detection rates if isolated, intact nucleoli as compared to
nucleoli subjected to denaturing conditions are used as source
for miRNA proﬁling. For this and subsequent analyses we decided
to use HeLa cells due to the abundance of miRNAs present, and our
previous comparative analyses on cellular and nucleolar proteins
and RNA in this cell line [39,45]. Accordingly, we subjected isolated
HeLa nucleoli to heat-denaturation (95 C, 5 min) or not, followed
by qPCR using TaqMan assay designed for detection of mature
miRNAs (Fig. 2A). Analysis of abundant, largely cytoplasmic RNAs
(hY1, hY3) or nuclear RNAs (U1, U2) showed that there was no dif-
ference in the ampliﬁcation cycles (Ct) between the denatured vs.
non-denatured nucleoli (DCt), whereas the DCt of snoRNAs RNU44
and RNU48 were close to 6 (Fig. 2B). In a further repeat of this
assay, RNU44 and RNU48 had DCt-values ofP7, representing over
128-fold higher detection rate in the denatured nucleolar sample
(Fig. 2C). Of three miRNAs tested in the same assay, DCt of miR-
100 was similar to the snoRNAs (DCt 7.8), and miR-23a was some-
what lower (DCt 5.4) (Fig. 2C). There was no change in miR-206,
included into the analysis based on a previous publication [16],
but which was present in HeLa at very low level (Fig. 2C). We con-
cluded that this approach provided a feasible way to enrich and
detect nucleolus-associated small RNAs.
We then conducted TaqMan miRNA array proﬁling of isolated
nucleoli using the comparative heat-denaturation protocol. To fur-
ther increase robustness, we limited the ampliﬁcation cycles to <38
to exclude rare and potentially contaminating signals. Of a total of
664 miRNAs represented by the array, 92 individual miRNAs were
detected (Fig. 3A). Of these, 32 miRNAs had DCtP 7, that is, were
128-fold more abundant in the heat-denatured nucleolus (Fig. 3B).
All snoRNA controls included in the array had DCt of over 10,
whereas small nuclear RNAs had <4 (Fig. 3B). Based on these
Fig. 1. MiRNA expression proﬁling of nucleolar RNA. (A) Small RNA isolation and analysis by 16% denaturing PAGE. Amount of RNA loaded is indicated at the top. (B, C) MiRNA
expression analysis using NCode Multi-Species array. (B) HeLa (N = 41 miRNA); (C) MCF7 (N = 48 miRNA). Scatter plot of nucleolar and total RNA intensities are shown. The
nucleolar intensities were adjusted according to snoRNA expression in the respective total cellular and nucleolar fraction. Scatter plots are thresholded at 8 (HeLa) and 6
(MCF7) to exlude low intensity miRNAs. (D) Top-ranking nucleolar miRNAs in HeLa and MCF7 cells. (E, F) Scatter plots of HeLa and MCF7 nucleolar (E) and cellular (F) miRNA
intensities (N = 36 miRNA). Pearson correlation coefﬁciencies (r) are indicated in each plot.
Fig. 2. Differential nucleolar RNA qPCR analysis protocol. (A) Scheme of nucleolar
denaturation and RT-PCR protocol. (B) Small RNA qPCR controls of denatured and
non-denatured nucleoli. Bars represent mean (N = 3 biological experiments) and
error bars SD. (C) qPCR for heat-denatured and non-denatured nucleoli for the
indicated small RNAs and miRNAs. DCt represents Ct denaturated nucleoli – Ct non-
denatured nucleoli.
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ity the presence of miRNAs in the nucleolar RNA preparation. The
identiﬁed nucleolar miRNAs included members of four miRNA
families, namely miR-17-92, miR-106a-363, miR-23a-24 and
miR-30 (Fig. 3C). This may be an indicator that these miRNAs share
regulatory pathways or functional activities relevant for their
nucleolar presence.3.2. Northern hybridization of miRNA in subcellular compartments
To ascertain the presence of miRNAs in the nucleolar RNA prep-
arations we conducted Northern hybridization of seven represen-
tative miRNAs. We assessed the presence of the miRNAs in the
nucleolar, nuclear, cytoplasmic and total cellular fractions. Cellular
fractionation and RNA isolation was performed as in our previous
studies [39,45] and manuscript submitted (Bai et al., submitted).
Equal amounts of RNA (25 lg) was loaded from each subcellular
fraction. The purity of the RNA preparations was conﬁrmed using
probes against several small RNAs. These included RNU44, a snoR-
NA abundantly expressed in the nucleolus, U11, a small nuclear
RNA with mostly nucleoplasmic localization, cyto-nucleoplasmic
tRNA, and hY1, a mostly cytoplasmic RNA. According to the North-
ern analysis, and analyses shown in Refs. [39,45], the nucleolar
RNA preparations were judged to be free of nucleoplasmic and
cytoplasmic RNA (Fig. 4A). To further test the purity of RNA isolates
we conducted qPCR using primers for cytoplasmic hY1 and nucle-
olar RNU44. The qPCR for hY1 and RNU44 conﬁrmed their enrich-
ment in the compartment-speciﬁc RNA preparations (Fig. 4C). As
shown in Fig. 4B, several miRNAs (miR-19b, miR-21, miR-24,
miR-30c, miR-31, miR-99a, miR-191) were detected in the nucleo-
lar fraction in their mature 20–23 nt forms, but were proportion-
ally much lower as compared to the total cellular RNA fraction.
Mature miRNAs were also detected in the nuclear RNA fraction.
This is consistent with recent deep sequencing of small RNAs,
which showed nuclear presence of over 60 mature miRNAs includ-
ing all miRNAs analyzed here [13].
3.3. Small RNA deep sequencing of the subcellular compartments
To provide a comprehensive and quantitative analysis of miRNA
abundance in the HeLa subcellular fractions, we used small RNA
deep sequencing. Following subcellular fractionation, RNA isola-
tion and separation, small RNAs (10–40 nt) were gel puriﬁed and
Fig. 3. MiRNA proﬁling using TaqMan miRNA expression array. (A) Waterfall plot of detectable nucleolar miRNAs. DCt represents Ct denaturated nucleoli – Ct non-denatured
nucleoli. (B) MiRNA nucleolar abundance as shown by ranking order of the DCt. Small nuclear (snRNA) and snoRNAs present in the TaqMan array are shown as controls. (C)
MiRNA families represented in the dataset.
Fig. 4. Northern analysis of miRNA presence in cellular compartments. RNA was isolated from nucleolar (No), nuclear (Nu) or cytoplasmic (Cyto) fractions or from total
cellular RNA (Ce). RNA (20 lg) was separated on 15% gel. The blots were probed for (A) known small RNAs or (B) miRNAs, as indicated. Size markers are indicated to the right.
Relative proportion of miRNAs is expressed as compared to total cellular RNA set as 1. (C) RNAs isolated from respective subcellular compartments were ampliﬁed using qPCR
with primers for RNU44 and hY1.
B. Bai et al. / FEBS Open Bio 4 (2014) 441–449 445used to generate cDNA libraries followed by deep sequencing using
Ion Torrent platform. Full data set is deposited as #GSE50057, and
detailed description of the small RNA annotation is provided in a
manuscript submitted (Bai et al., submitted). The analysis showed
that the nucleolar small RNome was unique and predominantlycomposed of snoRNA-derived small RNAs. Approximately
200,000 miRNA reads were detected in the total cellular, cytoplas-
mic and nuclear fraction each, and 2100 reads in the nucleolar RNA
library (Table 1 and Supplementary Table S2). Eleven miRNAs were
present in the nucleolar small RNA fraction at read numbers P10.
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21, miR-24, miR-31, miR-93, miR-151, miR-532, miR-574) and
scored positive in the nucleolus-denaturation protocol (Fig. 3B).
Overall, the miRNA reads between cytoplasmic and total RNA
and nuclear and total RNA showed linear distribution as displayed
in scatter plots, and very high correlation (Pearson correlation
coefﬁciency 0.998 and 0.997, respectively) (Supplementary
Fig. S1A and B). Scatter plot analyses of the distribution between
nucleolar and cytoplasmic or nuclear miRNAs were more diverse,
although a general trend of correlation between the read abun-Table 1
Ion Torrent miRNA reads and frequencies in cellular compartments. miRNAs present in th
Cellular %Cellular Cytoplasm %Cytopl
miR-24 20,998 11.12 18,051 9.02
miR-21 101,664 53.83 120,398 60.19
miR-93 1535 0.81 1072 0.54
miR-31 456 0.24 243 0.12
miR-19B 994 0.53 727 0.36
miR-1307 151 0.08 92 0.05
miR-574 42 0.02 38 0.02
miR-151 618 0.33 398 0.20
miR-532 174 0.09 100 0.05
miR-148 132 0.07 75 0.04
miR-18A 2283 1.21 1436 0.72
Sum 129,047 68.3 142,630 71.3
All miRNAs 188,852 100 200,033 100
Fig. 5. Relative abundance of miRNAs in the subcellular compartments as analyzed by de
MiRNAs with readsP10 in the nucleus, cytoplasm and total cellular fractions were ident
number of cellular reads. The nuclear/cytoplasmic read ratio is shown. Insets display miRN
compared to nuclear (gray bar) and cytoplasmic (black bars) reads are shown.dances was maintained (Supplementary Fig. S1C and D). The Pear-
son correlations between nucleolar and cytoplasmic or nuclear
reads were 0.634 and 0.735, respectively.
Given that small RNA deep sequencing of cytoplasmic and
nuclear fractions have indicated that mature miRNAs are fre-
quently present in the nucleus consistent with our results here,
we queried for this property by comparing reads of all miRNAs
present in both compartments at reads P10. For this purpose,
we normalized the numbers of nuclear and cytoplasmic reads
against the cellular reads, and then compared the relative ratiose nucleolus at reads P 0 are shown.
asm Nuclear %Nuclear Nucleolus %Nucleolar
34,499 17.45 972 46.26
118,190 59.77 691 32.89
1241 0.63 113 5.38
377 0.19 49 2.33
1075 0.54 34 1.62
97 0.05 38 1.81
87 0.04 24 1.14
657 0.33 19 0.90
179 0.09 17 0.81
122 0.06 15 0.71
2463 1.25 12 0.57
158,987 80.4 1984 94.4
197,731 100 2101 100
ep sequencing. (A) Comparison of miRNA reads between the nucleus and cytoplasm.
iﬁed (N = 127) and nuclear and cytoplasmic reads were normalized against the total
As in the highest and lowest 15% ratio. (B) Relative frequencies of nucleolar reads as
Fig. 6. Effect of CRM1 and Pol I transcription inhibition on nucleolar miRNA
abundance. Cells were treated with ActD (50 ng/ml) (A) or leptomycin B (LMB)
(10 lM) (B) for 3 h, fractionated and RNA was isolated. RNA (25 lg) was separated
on 15% gel and hybridized to respective LNA probes. Relative proportion of miRNAs
is expressed as compared to total cellular RNA set as 1. (C) Quantitative analysis of
B. Bai et al. / FEBS Open Bio 4 (2014) 441–449 447of nuclear and cytoplasmic reads. 17 miRNAs were 2-fold more
abundant in the nucleus than in the cytoplasm (Fig. 5A), and
included e.g. miR-29b previously shown to be stabilized in HeLa
cell nuclei [12]. Conversely, those miRNAs with higher relative
cytoplasmic abundances included seven members of miR-let-7
family and miR-34a (Fig. 5A).
We then compared the relative frequencies of the eleven nucle-
olar miRNA reads to their frequencies in the other cellular frac-
tions. This analysis showed that the frequencies of several
miRNAs were substantially higher in the nucleolus than in the
nuclear and cytoplasmic compartments (Fig. 5B). MiR-574, miR-
1307, miR-31, miR-148, miR-532 and miR-93 were proportionally
P8-fold more abundant in the nucleolus than in the other respec-
tive compartments (Fig. 5B). These ﬁndings suggested that several
miRNAs showed compartment-speciﬁc enrichment.
3.4. Dicer inactivation does not affect miRNA nucleolar accumulation
Dicer has been suggested to affect processing of certain snoR-
NAs to miRNA-sized fragments [40,41]. To address whether Dicer
affects miRNA nucleolar presence, we analyzed small RNAs from
Dicer/ HCT116 cells and the parent Dicer-proﬁcient HCT116
cells. It has been previously shown that miR-21 processing is
compromised in the Dicer/ HCT116 cells, whereas miR-31
processing to mature form is less affected [46]. We hence used
subcellular RNA fractions of the HCT116 parent and Dicer-null
derivative cells to analyze for miR-21 and miR-31 by Northern
blotting. As shown in Supplementary Fig. S2, miR-21 was propor-
tionally decreased in the Dicer-null cells in all cellular compart-
ments. Similarly, the decrease in abundance of miR-31 was
proportional. Hence, ablation of Dicer did not alter the nucleolar
presence of miR-21.
3.5. MiR-21 and miR-31 nucleolar association increases following
CRM1 inhibition
As shown by numerous studies, Pol I transcription blocks cause
nucleolar disintegration and reorganization of the nucleolar prote-
ome and RNome [28,39,47,48]. We therefore used Actinomycin D
(ActD) to inhibit Pol I to ask whether nucleolar miRNA abundance
would be affected. Interestingly, although the presence of hY1 was
increased in the nucleolar fraction of ActD-treated cells, that of
miR-31 was unaffected (Fig. 6A). This suggests that ongoing Pol I
transcription may not be required for the nucleolar presence of
miRNAs.
CRM1/NMD3 export/adaptor complex extensively accumulates
in the nucleolus when Pol I is inhibited [35,39]. This is especially
interesting as CRM1 is involved in the nucleolar trafﬁcking of snoR-
NA [33], and has been implicated in the trafﬁcking of miRNAs [49].
We treated the cells with a CRM1-speciﬁc inhibitor, leptomycin B.
Subcellular fractionation and analysis of miR-31 by Northern
hybridization indicated that the nucleolar abundance of miR-31
was increased by 3-fold in leptomycin B-treated cells (Fig. 6B
and C).(B) for miR-31 and hY1. Results represent the mean and SEM of two biological
experiments.4. Discussion
This is the ﬁrst small RNA deep sequencing study that addresses
small RNome of the nucleolus with speciﬁc reference to presence
of miRNAs in this subcellular compartment. We consistently detect
several miRNAs in the nucleolar RNA preparations using different
methodological approaches including two separate miRNA expres-
sion arrays, Northern analysis and small RNA deep sequencing. We
also established a new method to detect nucleolus-associated
small RNAs in the isolated nucleoli. Collectively, these resultsshowed that mature forms of over ten miRNAs were detected in
the nucleolus. MiRNA nucleolar localization was independent of
Dicer activity, but was dependent on CRM1. These data indicate
that small RNAs, including miRNA are discernible in the nucleolus
and expand the aspects of miRNA regulation and potential
functions.
There are no previous systematic unbiased approaches that
address the extent of human miRNAs in the nucleoli. Here we ﬁnd
448 B. Bai et al. / FEBS Open Bio 4 (2014) 441–449the presence of several miRNAs in the nucleoli using different
experimental approaches. The subcellular preparations used here
have been previously extensively analyzed for compartment-spe-
ciﬁc expression of both protein and RNA which validate their pur-
ity in addition to assays shown here [39,45, Bai et al., submitted].
Yet, it is possible that the miRNAs are retained in the perinucleolar
area rich in heterochromatin, or that the RNA preparations contain
other co-purifying RNA-rich complexes like those present in Cajal
bodies, or in cytoplasmic and nuclear RNAs. To address these
concerns, we designed and used an approach that employed
heat-denaturation of the isolated intact nucleoli and used this as
a source for qPCR. This approach indicated a signiﬁcant difference
in the ability to amplify nucleolar snoRNAs but not small nuclear
RNAs that were used as controls. Using this approach with a highly
restrictive cut-off at over 128-fold difference, 32 miRNAs were
identiﬁed as nucleolus-associated. Of these, 84% were present in
the NCode miRNA array at high intensity. Further, the presence
of miR-19b, miR-21, miR-24, miR-30c, miR-31, miR-99a and miR-
191 was conﬁrmed by Northern hybridization in the nucleolar
RNA fractions. RNA Seq of nucleolar small RNome identiﬁed eleven
miRNAs in the nucleolus (miR-24, miR-21, miR-93, miR-31, mir-
19B, miR-1307, miR-574, miR-151, miR-532, miR-148, miR-18A)
out of which eight were also highly differentially expressed in
the nucleolar denaturation assay (except for miR-1307, miR-148
and miR-18a either absent in the assay or ampliﬁable only in the
denatured nucleoli). These results strongly support the interpreta-
tion that miRNAs can be detected in the nucleoli although their
abundance is low compared to their presence in the cytoplasm.
Overall, this study identiﬁed several overlapping nucleolar miRNAs
to that of Li et al. [18] including miR-191, miR-484, miR-193b, miR-
93 and miR-574. Collectively, the data is consistent with the inter-
pretation that miRNAs are detectable in the nucleolar fractions.
We tested whether the regulation of nucleolar activity affects
miRNA nucleolar localization. Inhibition of Pol I transcription
which causes segregation of nucleolar structures had no effect on
miR-31 spatial distribution suggesting that it may be retained in
the nucleolar remnants. While XPO5 exports miRNAs to the cyto-
plasm, CRM1, involved both in ribosome and mRNA export [50],
is also a nucleolar resident [39], and mediates transfer of snoRNAs
to the nucleolus [33]. For these reasons we tested whether CRM1
could affect miRNA nucleolar abundance. We found here that inhi-
bition of CRM1 increased the presence of miR-31 in the nucleolus.
This is consistent with the ﬁnding of increased miRNA nuclear
accrual by Castanotto et al. [49]. As CRM1 inhibition has been
shown to affect nucleolar transit of U3 RNAs, it is possible that
CRM1 is involved in trafﬁcking of several small RNAs.
The relevance of miRNA nucleolar localization is currently
unknown. The typical miRNA targets are absent from the nucleo-
lus. The study by Li et al. [18] suggested that miRNA nucleolar
localization could be affected by exposure to DNA and ds RNA.
Given that RNA editing, especially A-to-I takes place in the nucleo-
lus [32,51], and that A-to-I editing has been observed in a high-
throughput sequencing study [52], we speciﬁcally searched for this
in the nucleolar deep sequencing data. However, no indication of
A-to-I editing among the nucleolar miRNA reads was detected
(not shown). Small RNAs such as siRNAs direct methylation of his-
tones and DNA thereby altering chromatin states and regulate the
activity of transposons and genomic areas rich in heterochromatin
and repetitive elements such as centromeres [53]. The perinucleo-
lar area is highly enriched in heterochromatin and rDNA genes
have a unique arrangement of active and epigenetically silenced
genes. The possibility that nucleolar miRNAs could be involved in
controlling nucleolar chromatin states is intriguing. In plants, siR-
NAs regulate rRNA gene promoter activity and govern nucleolar
dominance [54]. Although non-coding RNAs are critical regulatorsof rRNA transcription in mammals [55], miRNA-sized RNAs have
not been ascribed with similar activities.
The nucleolus is highly dynamic and its activity reﬂects the cel-
lular needs for protein synthesis. Many nucleolar proteins have
high mobility and constantly shuttle between the different cellular
compartments, and this dynamic mobility relates to shuttling of
rRNA components as well as small RNAs. Argonaute complexes
contain a large number of RNA metabolism-associated proteins
including gemins, helicases and hnRNP-proteins and co-sediment
with ribosomes [56,57]. Interestingly, many of the Argonaute-com-
plex associated proteins are also nucleolar. MiRNAs have been
detected in association with ribosomes, and nuclear import of ribo-
somal proteins is coordinated [58]. Therefore it is possible that
miRNAs shuttle with binding proteins or ribosomal particles to
the nucleolus. Hence, the contents of nucleolar proteome or
RNome cannot be strictly deﬁned, but rather reﬂect the present
state of cellular activity. Based on these dynamic properties we
believe it is likely that there is also great variability in the miRNA
content of the nucleolus that depends on the physiological state
and cell type in question.
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